Dare Bioscience, Inc. Accumulated Other Comprehensive Income
Dare Bioscience, Inc. (DARE) had Accumulated Other Comprehensive Income of -$374.86 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-13
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$374.86K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$377.08K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$421.62K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$395.97K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$374.86K 10-Q · filed 2026-08-13 |
| 2026-03-31 | -$377.08K 10-Q · filed 2026-05-14 |
| 2025-12-31 | -$421.62K 10-Q · filed 2026-08-13 |
| 2025-09-30 | -$395.97K 10-Q · filed 2025-11-13 |
| 2025-06-30 | -$402.83K 10-Q · filed 2025-08-14 |
| 2025-03-31 | -$415.72K 10-Q · filed 2025-05-13 |
| 2024-12-31 | -$428.81K 10-K · filed 2026-03-26 |
| 2024-09-30 | -$362.63K 10-Q · filed 2024-11-14 |
| 2024-06-30 | -$385.56K 10-Q · filed 2024-08-12 |
| 2024-03-31 | -$400.12K 10-Q · filed 2024-05-14 |
| 2023-12-31 | -$360.90K 10-K · filed 2025-03-31 |
| 2023-09-30 | -$419.50K 10-Q · filed 2023-11-09 |
| 2023-06-30 | -$404.47K 10-Q · filed 2023-08-10 |
| 2023-03-31 | -$373.32K 10-Q · filed 2023-05-11 |
| 2022-12-31 | -$351.31K 10-K · filed 2024-03-28 |
| 2022-09-30 | -$530.74K 10-Q · filed 2022-11-10 |
| 2022-06-30 | -$299.99K 10-Q · filed 2022-08-09 |
| 2022-03-31 | -$164.12K 10-Q · filed 2022-05-12 |
| 2021-12-31 | -$154.97K 10-K · filed 2023-03-30 |
| 2021-09-30 | -$170.39K 10-Q · filed 2021-11-10 |
| 2021-06-30 | -$107.11K 10-Q · filed 2021-08-12 |
| 2021-03-31 | -$98.23K 10-Q · filed 2021-05-13 |
| 2020-12-31 | -$91.39K 10-K · filed 2022-03-31 |
| 2020-09-30 | -$112.81K 10-Q · filed 2020-11-12 |
| 2020-06-30 | -$113.48K 10-Q · filed 2020-08-12 |
| 2020-03-31 | -$125.57K 10-Q · filed 2020-05-14 |
| 2019-12-31 | -$102.63K 10-K · filed 2021-03-30 |
| 2019-09-30 | -$112.40K 10-Q · filed 2019-11-12 |
| 2019-06-30 | -$97.02K 10-Q · filed 2019-08-14 |
| 2019-03-31 | -$89.11K 10-Q · filed 2019-05-14 |
| 2018-12-31 | -$96.73K 10-K · filed 2020-03-27 |
| 2018-09-30 | -$78.03K 10-Q · filed 2018-11-13 |
| 2018-06-30 | -$59.31K 10-Q · filed 2018-08-13 |
| 2018-03-31 | -$31.83K 10-Q · filed 2018-05-14 |
| 2017-12-31 | -$18.08K 10-K · filed 2019-04-01 |
| 2017-09-30 | -$9.77K 10-Q · filed 2017-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |